Connect with us

Health

COVID-19 outbreaks at meat processing plants are hitting minorities hard

Published

on

Workers from ethnic and minority groups make up nearly all meatpacking employees who’ve been infected during COVID-19 outbreaks at their facilities, a new government study reveals.

The stats show that nearly 1 of every 10 workers in affected plants were diagnosed with COVID-19, based on figures from 14 states that reported the total number of workers in facilities with outbreaks. Among infected workers, 87 percent were from racial or ethnic minorities.

There have been 16,233 reported COVID-19 cases at 239 meat and poultry processing facilities located in 23 states reporting stats to the U.S. Centers for Disease Control and Prevention through May 31, according to a July 7 analysis in the agency’s Morbidity and Mortality Weekly Report.

Of the workers with COVID-19 who reported their race or ethnicity, about 56 percent of infected employees were Hispanic and 19 percent were black, the report found. Whites represented 13 percent of cases, and Asians accounted for 12 percent.

“Ongoing efforts to reduce incidence and better understand the effects of COVID-19 on the health of racial and ethnic
minorities are important to ensure that workplace-specific prevention strategies and intervention messages are tailored
to those groups most affected by COVID-19,” the report concluded.

There were 86 deaths related to COVID-19 among the workers, the CDC reported.

The actual numbers are probably even higher than reported here, given that many states did not submit data for this report, the CDC researchers, led by Dr. Michelle Waltenburg, said.

Outbreaks at meatpacking plants were among the first signs that COVID-19 had started to reach into states previously unaffected by the coronavirus.

Meat and poultry processing plants employ an estimated 525,000 workers in about 3,500 facilities across the nation, the researchers said in background notes.

These new numbers show that “unsafe working conditions at meatpacking plants placed workers at high risk for COVID-19,” said Dr. Robert Glatter, an emergency physician at Lenox Hill Hospital in New York City.

Glatter cited crowded working conditions, a lack of personal protective equipment, and inconsistent testing for the coronavirus as some of the major factors in the outbreaks reported around the country.

According to the CDC report, of the facilities with COVID-19 cases, 111 plants in 14 states reported their efforts to protect workers from the coronavirus:

  • 80 percent said they screened workers upon entry,
  • 77 percent required face coverings,
  • 65 percent installed more hand hygiene stations,
  • 63 percent educated workers about how infectious diseases spread,
  • 62 percent installed physical barriers between workers,
  • 37 percent offered COVID-19 testing to employees,
  • 22 percent closed temporarily to halt or prevent an outbreak.

An infected person who coughs or sneezes produces aerosolized droplets that can remain airborne for at least eight to 14 minutes, Glatter noted.

“Knowing this, it’s essential that workers in meatpacking plants wear PPE, and have physical partitions along with adequate physical distance between them to reduce risk of transmission,” Glatter said.

The CDC recommended in its report that plants also provide culturally appropriate health education materials to workers, encourage employees to take sick leave when needed, and screen workers for possible infection.

However, efforts to screen workers as they enter the plant are probably futile since infected people without symptoms account for a large percentage of COVID-19 cases, Glatter said.

“Temperature checks and symptom screening have limited value,” Glatter said.

More information

The U.S. Centers for Disease Control and Prevention has more about COVID-19.

Copyright 2020 HealthDay. All rights reserved.



Source link

Health

Common meds linked to faster mental decline in seniors

Published

on

A group of widely used medications might speed up older adults’ mental decline — especially if they are at increased risk of dementia, a new study hints.

The medications in question are called anticholinergics, and they are used to treat a diverse range of conditions — from allergies, motion sickness and overactive bladder to high blood pressure, depression and Parkinson’s disease.

The drugs are known to have short-term side effects such as confusion and fuzzy memory.

But studies in recent years have turned up a more troubling connection: a heightened risk of dementia among long-term users.

The new findings, published Sept. 2 in Neurology, add another layer: Healthy older adults on these medications had an increased risk of developing mild cognitive impairment. That refers to subtler problems with memory and thinking that may progress to dementia.

And the link, researchers found, was strongest among two groups of people already at heightened risk of Alzheimer’s disease: those who carry a gene variant that raises the odds of the disease, and people with certain biological “markers” of the disease in their spinal fluid.

The results do not prove anticholinergic drugs are to blame, cautioned Heather Snyder, vice president of medical and scientific relations at the Alzheimer’s Association.

“This study shows an association in a very specific population, but it does not prove causation,” said Snyder, who was not involved in the research.

However, it is biologically plausible that the drugs could increase dementia risk, said Dr. Allison Reiss, an associate professor at NYU Long Island School of Medicine.

The medications, she said, block a chemical called acetylcholine, which transmits messages among nerve cells. Acetylcholine is involved in memory and learning, and is typically low in people with Alzheimer’s.

“The preponderance of evidence suggests it’s better to avoid these medications in older adults,” said Reiss, who is also an advisory board member at the Alzheimer’s Foundation of America.

That’s especially true, she added, when alternatives exist.

Many medications sold for allergies, colds and coughs have anticholinergic properties — and are available over-the-counter. So it’s important, Reiss said, that older adults be aware that non-prescription drugs are not automatically “safe.”

“You don’t want to add any medications that aren’t necessary,” said Reiss, who had no role in the study.

Meanwhile, certain prescription drugs for depression, high blood pressure, Parkinson’s disease and schizophrenia have anticholinergic properties, as do medications for overactive bladder and urinary incontinence.

Reiss said that people with questions about their prescriptions should talk to their doctor.

For the new study, researchers led by Lisa Delano-Wood, from the University of California, San Diego, followed 688 older adults who initially had no problems with memory or thinking skills. One-third said they’d been regularly taking anticholinergic drugs for more than six months — usually far more than one.

In fact, they were taking an average of almost five medications per person.

Over the next 10 years, people on anticholinergics were more likely to develop mild cognitive impairment, which was gauged through yearly tests. Over half — 51% — developed the condition, versus 42% of older adults not taking anticholinergics.

The researchers did consider other factors that affect dementia risk — such as people’s education levels and history of heart disease or stroke. And after adjusting for those factors, older adults on anticholinergics were still 47% more likely to develop mild impairment.

The link was even stronger among people who carried a gene variant that raises Alzheimer’s risk: Anticholinergic use more than doubled their risk of impairment. A similar pattern was seen among study participants with Alzheimer’s-linked proteins in their spinal fluid.

That, Reiss said, suggests the medications might have “accelerated a process that was already in place.”

Snyder said the results “illustrate that we need better treatments — not only for Alzheimer’s and other dementias, but for other common conditions associated with aging.”

More information

The University of British Columbia has more on anticholinergic drugs.

Copyright 2020 HealthDay. All rights reserved.



Source link

Continue Reading

Health

Even ‘social smokers’ up their odds of death from lung disease

Published

on

Even light smokers are much more likely to die of lung disease or lung cancer than nonsmokers, a new study warns.

“Everyone knows that smoking is bad for you, but it’s easy to assume that if you only smoke a little, the risks won’t be too high,” said study co-leader Pallavi Balte, of Columbia University Irving Medical Center, in New York City.

The new study shows how wrong that thinking can be. It included nearly 19,000 people in the United States, average age 61, who were followed for an average of 17 years. During that time, nearly 650 died of lung disease (such as emphysema) and 560 died of lung cancer.

Among nonsmokers, less than 2% died from lung disease and less than 1% died from lung cancer. But among social smokers (fewer than 10 cigarettes a day), those numbers were over 3% and close to 5%, respectively.

Not surprisingly, heavy smokers (more than 20 cigarettes a day) fared worst, with more than 10% dying from lung disease and about 13% from lung cancer, the study found.

After accounting for other potential factors — such as age, sex, race, level of education and body weight — the researchers concluded that social smokers were 2.5 times more likely to die of lung disease and 8.6 times more likely to die of lung cancer than nonsmokers.

Social smokers had around half the rate of death from lung disease as heavy smokers, but their rate of lung cancer death was two-thirds that of heavy smokers, according to the study.

The results were scheduled for presentation at a virtual meeting of the European Respiratory Society. Data and conclusions presented at meetings should be considered preliminary until peer-reviewed.

The findings show that cutting down on smoking is no substitute for quitting, the researchers concluded.

“Previous research suggests that people are cutting down on smoking. For example, in the U.S.A., the proportion of smokers smoking less than 10 cigarettes per day has increased from 16% to 27%,” Balte said in a society news release.

“You might think that if you only smoke a few cigarettes a day you are avoiding most of the risk. But our findings suggest that social smoking is disproportionately harmful,” Balte said.

If you don’t want to die of lung cancer or respiratory disease, the best action is to quit completely, she added.

More information

The U.S. Centers for Disease Control and Prevention offers a guide for quitting smoking.

Copyright 2020 HealthDay. All rights reserved.



Source link

Continue Reading

Health

Antidepressant use rising in U.S., mostly in women, CDC says

Published

on

Sept. 4 (UPI) — Nearly 18% of all adult women in the United States used antidepressant medication between 2015 and 2018, compared to just over 8% of men, according to data released Friday by the Centers for Disease Control and Prevention.

Overall, during the decade between 2009-2010 and 2017-2018, antidepressant use increased to 14% from 11%, the agency found. Use increased more for women — to 19% from 14% — than for men — to 9% from 7%.

In 2018, slightly more than 7% of adults in the United States said they suffered from a “major depressive episode,” the agency said.

The findings are based on an analysis of data from the National Health and Nutrition Examination Survey for the 10-year period between 2009 and 2018.

Depression is a mental health disorder in which sufferers experience a persistent depressed mood or loss of interest in activities, causing significant impairment in daily life, according to the National Institute of Mental Health.

Antidepressant medications are used to reduce the symptoms of depression, and include selective serotonin reuptake inhibitors, or SSRIs, and serotonin and norepinephrine reuptake inhibitors, or SNRIs.

From 2015 through 2018, antidepressant use increased with age and was highest among women aged 60 and over, at slightly more than 24%, the CDC found.

In addition, use of the drugs was higher among non-Hispanic White adults, at 17%, compared with non-Hispanic Black adults, at 8%, and non-Hispanic Asian adults, at 3%.

Adults with at least some college education were more likely to use antidepressants than those with a high school education or less, the agency said.



Source link

Continue Reading

Trending